CRESCENT BIOPHARMA INC (CBIO) Stock Income Statement
NASDAQ:CBIO - Nasdaq - US38000Q1022 - Common Stock - Currency: USD
| TTM (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 794.00K | 7.34M | 20.95M | 0.00 | |||
| Cost Of Goods | 0.00 | 798.00K | 7.38M | 9.16M | N/A | |||
| Gross Profit | 0.00 | -4.00K | -42.00K | 11.79M | N/A | |||
| Operating Expenses | 13.55M | 29.40M | 87.85M | 68.36M | 57.28M | |||
| Research and Development | 1.98M | 12.44M | 68.89M | 52.18M | 43.86M | |||
| Selling, General, and Administrative Expenses | 12.77M | 16.97M | 18.96M | 16.18M | 13.42M | |||
| Operating Income | -13.55M | -29.41M | -87.89M | -56.57M | -57.28M | |||
| Interest Income/Expense | 383.00K | 537.00K | 39.00K | 560.00K | 2.15M | |||
| Other Income/Expense | N/A | 0.00 | -78.00K | 570.00K | -50.00K | |||
| Non Recurring Items | -30.71M | 20.98M | N/A | -800.00K | N/A | |||
| Income Before Taxes | -43.88M | -7.89M | -87.93M | -56.24M | -55.18M | |||
| Income Tax | 364.00K | 348.00K | N/A | N/A | N/A | |||
| Net Income | -44.24M | -8.24M | -87.93M | -56.24M | -55.18M | |||
| EBITDA | N/A | -29.18M | -87.60M | -56.47M | -57.18M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.37 | -0.26 | -2.87 | -2.93 | -4.60 | |||
| Non GAAP EPS | N/A | N/A | -2.87 | -2.83 | -4.60 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | -0.50% | -0.57% | 56.28% | N/A | |||
| Profit Margin | N/A | -1038.04% | -1198.32% | -268.45% | N/A | |||
| Operating Profit Margin | N/A | -3703.65% | -1197.79% | -270.02% | N/A | |||
All data in USD